ONCOLYTICS BIOTECH INC. Weighted Average Fair Value At Measurement Date Share Options Granted
ONCOLYTICS BIOTECH INC. (ONCY) had Weighted Average Fair Value At Measurement Date Share Options Granted of CAD 0.57 as of 2024-12-31, per its 20-F filed 2025-03-07.
Financial Statements › Notes
ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted · last filed 2025-03-07
- 2024-12-31: Weighted Average Fair Value At Measurement Date Share Options Granted 0.57 CAD.
- 2023-12-31: Weighted Average Fair Value At Measurement Date Share Options Granted 1.12 CAD.
- 2022-12-31: Weighted Average Fair Value At Measurement Date Share Options Granted 1.24 CAD.
- 2021-12-31: Weighted Average Fair Value At Measurement Date Share Options Granted 1.99 CAD.
| Period end | Weighted Average Fair Value At Measurement Date Share Options Granted | Weighted Average Fair Value At Measurement Date Share Options Granted as first filed |
|---|---|---|
| 2024-12-31 | 0.57 CAD 20-F · filed 2025-03-07 | |
| 2023-12-31 | 1.12 CAD 20-F · filed 2025-03-07 | |
| 2022-12-31 | 1.24 CAD 20-F · filed 2025-03-07 | |
| 2021-12-31 | 1.99 CAD 20-F · filed 2024-03-12 | |
| 2020-12-31 | 2.12 CAD 20-F · filed 2023-03-03 | |
| 2019-12-31 | 0.87 CAD 20-F · filed 2022-03-03 | |
| 2018-12-31 | 2.67 CAD 20-F · filed 2021-03-05 | |
| 2017-12-31 | 2.65 CAD 20-F · filed 2020-03-06 | 0.28 CAD 20-F · filed 2018-03-19 |
| 2016-12-31 | 1.59 CAD 20-F · filed 2019-03-15 | 0.17 CAD 20-F · filed 2018-03-19 |
| 2015-12-31 | 0.24 CAD 20-F · filed 2018-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |